 | INmune Bio Inc. | |||
| NCM : INMB || Location: United States | ||||
$10.62+2.26 (+26.94%) |
0.69 M | 8.4 - 10.73 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.526 M |
| March 15, 2024 | 1.444 M |
| Feb. 29, 2024 | 1.394 M |
| Feb. 15, 2024 | 1.174 M |
| Jan. 31, 2024 | 1.174 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.45 | -0.47 | -4.72% |
| 09/30/2023 | -0.40 | -0.48 | -19.14% |
| 06/30/2023 | -0.40 | -0.36 | 11.02% |
| 03/31/2023 | -0.02 | -0.36 | -1664.71% |
| 12/31/2022 | -0.49 | -0.32 | 35.31% |
INMB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 18.203M | Shares Float | 11.735M |
| Short Float | 1.526M | Market Cap | 193.32M |
| Institution ownership | 13.70% | Insider ownership | 34.569% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.67 | Forward EPS | -1.95 |